Sanket Koul

The three-member committee will assess the effectiveness of the UCPMP, examine enforcement mechanisms and recommend measures to curb unethical pharmaceutical marketing practices

AIMED calls for stricter inspections, traceable disposal records and clear liability rules to protect patient safety

Torrent Pharma's Q2FY27 net profit declined 9.6 per cent to ₹534 crore despite a 50.8 per cent rise in revenue, as higher finance costs and depreciation weighed on earnings

The vaccine will be priced at €5.50 per dose from early 2027 under a Gavi-UNICEF agreement, with expected savings of $50 million through 2029

The companies will develop 164 senior living units at Sarvam DXP in Gurugram, with prices starting at around Rs 3.7 crore per unit and handover expected in 48 months

The NPPA's 30% trade margin cap on 137 oncology drugs, effective November 9, has drawn support from the pharma industry, while patient groups question its impact on affordability.

New prices set to come into effect from November 9, 2026; state drug controllers to monitor implementation

The ₹1,450-crore IPO comprises a ₹500-crore fresh issue and a ₹950-crore offer for sale, while the hospital chain plans to add 800 beds through projects in Gurugram and Ludhiana

The move is expected to reduce export approval timelines for biologics manufacturers using different brand names in overseas markets, provided the products are already approved in India

Union Health Ministry seeks prominent display of healthcare service charges and package rates for foreign patients travelling to India on medical or Ayush visas to improve transparency.

Bench questions steep mark-ups on medicines and medical devices; Centre says price regulation must balance affordability with availability

Domestic manufacturers want importers' margins included in a uniform trade margin framework for medical devices, with a pilot covering high-volume consumables such as IV sets

Move could cut MRPs by up to 70%, save patients ₹2,500 crore annually; comes amid SC scrutiny of high mark-ups

Volume growth reached 3.5 per cent, the highest in two years, while pricing rose about 6.2 per cent as most therapy segments recorded stronger demand

Drug regulators in Maharashtra, Karnataka and Uttar Pradesh are gathering data on price mark-ups, potentially strengthening the case for a review of trade margin rationalisation

All 172 four-bedroom units at DLF's Aureva project in Gurugram were sold at an average ticket price of ₹11.5 crore, with NRIs accounting for 25 per cent of buyers

Rising affluence, longer life expectancy and changing family structures are drawing mainstream developers to premium senior living projects in India's major urban markets

The Drugs Consultative Committee has sought a detailed proposal from Rajasthan amid concerns that machinery from closed pharma units could be used to make spurious drugs

The Drugs Consultative Committee has sought the DGHS opinion and data on Merbromin's manufacture and use before deciding on its continued inclusion under Schedule K

Funding will be part of a new track under the PRIP scheme exclusively for start-ups and MSMEs at the initial research stage, with assistance of up to ₹50 crore per project